CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.40), $0.06 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $7.44 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.